Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MBIO | US
-0.00
-1.23%
Healthcare
Biotechnology
30/06/2024
17/10/2024
0.22
0.22
0.23
0.22
Mustang Bio Inc. a clinical-stage biopharmaceutical company focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers solid tumors and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. The company develops MB-107 and MB-207 a gene therapy program for X-linked severe combined immunodeficiency a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm acute myeloid leukemia and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108 a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester Massachusetts.
View LessLow Debt to Equity (< 0.25)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
47.4%1 month
67.0%3 months
94.2%6 months
688.0%-
-
31.75
-0.13
0.13
-0.14
-
-
-30.50M
8.08M
8.08M
-
-
-
-
-1.19K
0.64
1.06
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.03
Range1M
0.06
Range3M
0.27
Rel. volume
0.75
Price X volume
71.61K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Soligenix Inc | SNGX | Biotechnology | 3.63 | 8.47M | 2.83% | n/a | 84.28% |
Arsanis Inc | ASNS | Biotechnology | 1.4 | 8.43M | 1.45% | n/a | 252.35% |
Galecto Inc | GLTO | Biotechnology | 6.73 | 8.40M | 0.30% | n/a | 0.33% |
Plus Therapeutics Inc | PSTV | Biotechnology | 1.41 | 8.31M | -1.40% | n/a | -45.04% |
Pulmatrix Inc | PULM | Biotechnology | 2.03 | 7.41M | -4.70% | n/a | 0.18% |
Alzamend Neuro Inc. Common Stock | ALZN | Biotechnology | 1.64 | 7.34M | -1.20% | n/a | 0.00% |
TFFP | TFFP | Biotechnology | 2.06 | 7.14M | -1.44% | n/a | 1.26% |
Portage Biotech Inc | PRTG | Biotechnology | 6.71 | 7.04M | 0.15% | 0.27 | 1.47% |
Moleculin Biotech Inc | MBRX | Biotechnology | 2.36 | 6.71M | -2.48% | n/a | 3.00% |
Purple Biotech Ltd | PPBT | Biotechnology | 4.18 | 6.55M | 1.95% | n/a | 0.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.14 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 31.75 | 15.30 | Expensive |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 94.21 | 72.92 | Riskier |
Debt to Equity | -0.13 | -1.24 | Expensive |
Debt to Assets | 0.13 | 0.25 | Cheaper |
Market Cap | 8.08M | 3.78B | Emerging |